Clinical Trial Update: Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating cyclophosphamide for acute exacerbation of idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: COMPLETED